仁合熙德隆药业

Jiangxi Renhe Xidelong Pharmaceutical Co., Ltd. is a prominent pharmaceutical manufacturing subsidiary of the Renhe Group, based in the Medicine Capital of Zhangshu, Jiangxi Province, China. Established in 2002, the company serves as a core production base for the group's extensive portfolio of traditional Chinese medicines (TCM) and chemical pharmaceuticals. Its facilities are GMP-certified and equipped to produce various dosage forms, including capsules, tablets, and granules, with a focus on high-volume output for the over-the-counter (OTC) market. The company's products cover a wide range of therapeutic areas such as respiratory health, digestive disorders, and anti-inflammatory treatments. By leveraging Renhe Group's powerful nationwide distribution network, Renhe Xidelong plays a critical role in the commercial success of the Renhe brand across China.